The market doesn't appear to be overly excited about it ?
Perhaps due to the ambiguity of the announcement - no specific product mentioned and no upfront payment ?
Initial project is for the development of DEP® conjugates for an anti-infective drug, with an ability to add additional programs in other therapeutic areas.
Does anybody else think this is perhaps 'treading' on AstraZeneca's toes ? Or at the very least signing away AstraZeneca's rights in China / Asia for conjugates given our AZD0466 (DEP® Bcl2/xL conjugate) deal ? @Ima Scientist - thoughts ?
Agree @gaucau ... not overly excited about the "China" aspect .... especially given their reputation regarding accusations of patent copying / stealing - just sayin' ... have we done a deal with the devil ?
- Forums
- ASX - By Stock
- SPL
- Ann: Starpharma signs new DEP partnership with Chase Sun
Ann: Starpharma signs new DEP partnership with Chase Sun, page-7
-
- There are more pages in this discussion • 89 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.64M |
Open | High | Low | Value | Volume |
9.7¢ | 9.7¢ | 9.5¢ | $19.64K | 204.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 69731 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 5390 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 69731 | 0.095 |
2 | 305855 | 0.094 |
2 | 320000 | 0.093 |
1 | 100000 | 0.092 |
4 | 49861 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 5390 | 1 |
0.098 | 200000 | 1 |
0.100 | 106000 | 3 |
0.105 | 148467 | 3 |
0.110 | 183058 | 5 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |